Specific immunotherapy modifies allergen-specific CD4+ T-cell responses in an epitope-dependent manner
Understanding the mechanisms by which the immune system induces and controls allergic inflammation at the T-cell epitope level is critical for the design of new allergy vaccine strategies. We sought to characterize allergen-specific T-cell responses linked with allergy or peripheral tolerance and to...
Saved in:
Published in | Journal of allergy and clinical immunology Vol. 133; no. 3; pp. 872 - 879.e7 |
---|---|
Main Authors | , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
New York, NY
Elsevier Inc
01.03.2014
Elsevier Elsevier Limited |
Subjects | |
Online Access | Get full text |
ISSN | 0091-6749 1097-6825 1097-6825 |
DOI | 10.1016/j.jaci.2013.10.054 |
Cover
Loading…
Abstract | Understanding the mechanisms by which the immune system induces and controls allergic inflammation at the T-cell epitope level is critical for the design of new allergy vaccine strategies.
We sought to characterize allergen-specific T-cell responses linked with allergy or peripheral tolerance and to determine how CD4+ T-cell responses to individual allergen-derived epitopes change over allergen-specific immunotherapy.
Timothy grass pollen (TGP) allergy was used as a model for studying grass pollen allergies. The breadth, magnitude, epitope hierarchy, and phenotype of the DR04:01-restricted TGP-specific T-cell responses in 10 subjects with grass pollen allergy, 5 nonatopic subjects, and 6 allergy vaccine–treated subjects was determined by using an ex vivo peptide–MHC class II tetramer approach.
CD4+ T cells in allergic subjects are directed to a broad range of TGP epitopes characterized by defined immunodominance hierarchy patterns and with distinct functional profiles that depend on the epitope recognized. Epitopes that are restricted specifically to either TH2 or TH1/TR1 responses were identified. Allergen-specific immunotherapy was associated with preferential deletion of allergen-specific TH2 cells and without a significant change in the frequency of TH1/TR1 cells.
Preferential allergen-specific TH2 cell deletion after repeated high-dose antigen stimulation can be another independent mechanism to restore tolerance to allergen during immunotherapy. |
---|---|
AbstractList | Understanding the mechanisms by which the immune system induces and controls allergic inflammation at the T-cell epitope level is critical for the design of new allergy vaccine strategies.
We sought to characterize allergen-specific T-cell responses linked with allergy or peripheral tolerance and to determine how CD4(+) T-cell responses to individual allergen-derived epitopes change over allergen-specific immunotherapy.
Timothy grass pollen (TGP) allergy was used as a model for studying grass pollen allergies. The breadth, magnitude, epitope hierarchy, and phenotype of the DR04:01-restricted TGP-specific T-cell responses in 10 subjects with grass pollen allergy, 5 nonatopic subjects, and 6 allergy vaccine-treated subjects was determined by using an ex vivo peptide-MHC class II tetramer approach.
CD4(+) T cells in allergic subjects are directed to a broad range of TGP epitopes characterized by defined immunodominance hierarchy patterns and with distinct functional profiles that depend on the epitope recognized. Epitopes that are restricted specifically to either TH2 or TH1/TR1 responses were identified. Allergen-specific immunotherapy was associated with preferential deletion of allergen-specific TH2 cells and without a significant change in the frequency of TH1/TR1 cells.
Preferential allergen-specific TH2 cell deletion after repeated high-dose antigen stimulation can be another independent mechanism to restore tolerance to allergen during immunotherapy. Understanding the mechanisms by which the immune system induces and controls allergic inflammation at the T-cell epitope level is critical for the design of new allergy vaccine strategies. We sought to characterize allergen-specific T-cell responses linked with allergy or peripheral tolerance and to determine how CD4+ T-cell responses to individual allergen-derived epitopes change over allergen-specific immunotherapy. Timothy grass pollen (TGP) allergy was used as a model for studying grass pollen allergies. The breadth, magnitude, epitope hierarchy, and phenotype of the DR04:01-restricted TGP-specific T-cell responses in 10 subjects with grass pollen allergy, 5 nonatopic subjects, and 6 allergy vaccine–treated subjects was determined by using an ex vivo peptide–MHC class II tetramer approach. CD4+ T cells in allergic subjects are directed to a broad range of TGP epitopes characterized by defined immunodominance hierarchy patterns and with distinct functional profiles that depend on the epitope recognized. Epitopes that are restricted specifically to either TH2 or TH1/TR1 responses were identified. Allergen-specific immunotherapy was associated with preferential deletion of allergen-specific TH2 cells and without a significant change in the frequency of TH1/TR1 cells. Preferential allergen-specific TH2 cell deletion after repeated high-dose antigen stimulation can be another independent mechanism to restore tolerance to allergen during immunotherapy. Background: Understanding the mechanisms by which the immune system induces and controls allergic inflammation at the T-cell epitope level is critical for the design of new allergy vaccine strategies. Understanding the mechanisms by which the immune system induces and controls allergic inflammation at the T-cell epitope level is critical for the design of new allergy vaccine strategies.BACKGROUNDUnderstanding the mechanisms by which the immune system induces and controls allergic inflammation at the T-cell epitope level is critical for the design of new allergy vaccine strategies.We sought to characterize allergen-specific T-cell responses linked with allergy or peripheral tolerance and to determine how CD4(+) T-cell responses to individual allergen-derived epitopes change over allergen-specific immunotherapy.OBJECTIVEWe sought to characterize allergen-specific T-cell responses linked with allergy or peripheral tolerance and to determine how CD4(+) T-cell responses to individual allergen-derived epitopes change over allergen-specific immunotherapy.Timothy grass pollen (TGP) allergy was used as a model for studying grass pollen allergies. The breadth, magnitude, epitope hierarchy, and phenotype of the DR04:01-restricted TGP-specific T-cell responses in 10 subjects with grass pollen allergy, 5 nonatopic subjects, and 6 allergy vaccine-treated subjects was determined by using an ex vivo peptide-MHC class II tetramer approach.METHODSTimothy grass pollen (TGP) allergy was used as a model for studying grass pollen allergies. The breadth, magnitude, epitope hierarchy, and phenotype of the DR04:01-restricted TGP-specific T-cell responses in 10 subjects with grass pollen allergy, 5 nonatopic subjects, and 6 allergy vaccine-treated subjects was determined by using an ex vivo peptide-MHC class II tetramer approach.CD4(+) T cells in allergic subjects are directed to a broad range of TGP epitopes characterized by defined immunodominance hierarchy patterns and with distinct functional profiles that depend on the epitope recognized. Epitopes that are restricted specifically to either TH2 or TH1/TR1 responses were identified. Allergen-specific immunotherapy was associated with preferential deletion of allergen-specific TH2 cells and without a significant change in the frequency of TH1/TR1 cells.RESULTSCD4(+) T cells in allergic subjects are directed to a broad range of TGP epitopes characterized by defined immunodominance hierarchy patterns and with distinct functional profiles that depend on the epitope recognized. Epitopes that are restricted specifically to either TH2 or TH1/TR1 responses were identified. Allergen-specific immunotherapy was associated with preferential deletion of allergen-specific TH2 cells and without a significant change in the frequency of TH1/TR1 cells.Preferential allergen-specific TH2 cell deletion after repeated high-dose antigen stimulation can be another independent mechanism to restore tolerance to allergen during immunotherapy.CONCLUSIONSPreferential allergen-specific TH2 cell deletion after repeated high-dose antigen stimulation can be another independent mechanism to restore tolerance to allergen during immunotherapy. Background Understanding the mechanisms by which the immune system induces and controls allergic inflammation at the T-cell epitope level is critical for the design of new allergy vaccine strategies. Objective We sought to characterize allergen-specific T-cell responses linked with allergy or peripheral tolerance and to determine how CD4+ T-cell responses to individual allergen-derived epitopes change over allergen-specific immunotherapy. Methods Timothy grass pollen (TGP) allergy was used as a model for studying grass pollen allergies. The breadth, magnitude, epitope hierarchy, and phenotype of the DR04:01-restricted TGP-specific T-cell responses in 10 subjects with grass pollen allergy, 5 nonatopic subjects, and 6 allergy vaccine–treated subjects was determined by using an ex vivo peptide–MHC class II tetramer approach. Results CD4+ T cells in allergic subjects are directed to a broad range of TGP epitopes characterized by defined immunodominance hierarchy patterns and with distinct functional profiles that depend on the epitope recognized. Epitopes that are restricted specifically to either TH 2 or TH 1/TR 1 responses were identified. Allergen-specific immunotherapy was associated with preferential deletion of allergen-specific TH 2 cells and without a significant change in the frequency of TH 1/TR 1 cells. Conclusions Preferential allergen-specific TH 2 cell deletion after repeated high-dose antigen stimulation can be another independent mechanism to restore tolerance to allergen during immunotherapy. Background Understanding the mechanisms by which the immune system induces and controls allergic inflammation at the T-cell epitope level is critical for the design of new allergy vaccine strategies. Objective We sought to characterize allergen-specific T-cell responses linked with allergy or peripheral tolerance and to determine how CD4+T-cell responses to individual allergen-derived epitopes change over allergen-specific immunotherapy. Methods Timothy grass pollen (TGP) allergy was used as a model for studying grass pollen allergies. The breadth, magnitude, epitope hierarchy, and phenotype of the DR04:01-restricted TGP-specific T-cell responses in 10 subjects with grass pollen allergy, 5 nonatopic subjects, and 6 allergy vaccine-treated subjects was determined by using anex vivopeptide-MHC class II tetramer approach. Results CD4+T cells in allergic subjects are directed to a broad range of TGP epitopes characterized by defined immunodominance hierarchy patterns and with distinct functional profiles that depend on the epitope recognized. Epitopes that are restricted specifically to either TH2 or TH1/TR1 responses were identified. Allergen-specific immunotherapy was associated with preferential deletion of allergen-specific TH2 cells and without a significant change in the frequency of TH1/TR1 cells. Conclusions Preferential allergen-specific TH2 cell deletion after repeated high-dose antigen stimulation can be another independent mechanism to restore tolerance to allergen during immunotherapy. |
Author | DeLong, Jonathan H. Kwok, William W. Wambre, Erik Durham, Stephen R. Till, Stephen J. Torres-Chinn, Nadia Möbs, Christian Robinson, David Pfützner, Wolfgang James, Eddie A. |
AuthorAffiliation | 3 Department of Allergy and Clinical Immunology, National Heart and Lung Institute, Imperial College, London, United Kingdom 1 Benaroya Research Institute at Virginia Mason, Seattle, WA, USA 4 Allergy, Asthma and Lung Biology, King’s College London, United Kingdom 6 Department of Medicine, University of Washington, Seattle, WA 5 Allergy, Asthma and Lung Biology, King’s College London, United Kingdom 2 Department of Dermatology and Allergology, University Medical Center, Marburg, Germany |
AuthorAffiliation_xml | – name: 4 Allergy, Asthma and Lung Biology, King’s College London, United Kingdom – name: 6 Department of Medicine, University of Washington, Seattle, WA – name: 1 Benaroya Research Institute at Virginia Mason, Seattle, WA, USA – name: 2 Department of Dermatology and Allergology, University Medical Center, Marburg, Germany – name: 3 Department of Allergy and Clinical Immunology, National Heart and Lung Institute, Imperial College, London, United Kingdom – name: 5 Allergy, Asthma and Lung Biology, King’s College London, United Kingdom |
Author_xml | – sequence: 1 givenname: Erik surname: Wambre fullname: Wambre, Erik organization: Benaroya Research Institute at Virginia Mason, Seattle, Wash – sequence: 2 givenname: Jonathan H. surname: DeLong fullname: DeLong, Jonathan H. organization: Benaroya Research Institute at Virginia Mason, Seattle, Wash – sequence: 3 givenname: Eddie A. surname: James fullname: James, Eddie A. organization: Benaroya Research Institute at Virginia Mason, Seattle, Wash – sequence: 4 givenname: Nadia surname: Torres-Chinn fullname: Torres-Chinn, Nadia organization: Benaroya Research Institute at Virginia Mason, Seattle, Wash – sequence: 5 givenname: Wolfgang surname: Pfützner fullname: Pfützner, Wolfgang organization: Department of Dermatology and Allergology, University Medical Center, Marburg, Germany – sequence: 6 givenname: Christian surname: Möbs fullname: Möbs, Christian organization: Department of Dermatology and Allergology, University Medical Center, Marburg, Germany – sequence: 7 givenname: Stephen R. surname: Durham fullname: Durham, Stephen R. organization: Department of Allergy and Clinical Immunology, National Heart and Lung Institute, Imperial College, London, United Kingdom – sequence: 8 givenname: Stephen J. surname: Till fullname: Till, Stephen J. organization: Allergy, Asthma and Lung Biology, King’s College London, London, United Kingdom – sequence: 9 givenname: David surname: Robinson fullname: Robinson, David organization: Virginia Mason Medical Center, Seattle, Wash – sequence: 10 givenname: William W. surname: Kwok fullname: Kwok, William W. email: bkwok@benaroyaresearch.org organization: Benaroya Research Institute at Virginia Mason, Seattle, Wash |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=28383894$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/24373351$$D View this record in MEDLINE/PubMed |
BookMark | eNqNkl1rFDEUhoNU7Hb1D3ghAyIIMmu-5iMiBdn6BQUvWq9DNnPSZp1JxmSmsP--me6u1QWr5CLk5Dlvzjl5T9CR8w4Qek7wgmBSvl0v1krbBcWEpcACF_wRmhEsqrysaXGEZhgLkpcVF8foJMY1TmdWiyfomHJWMVaQGTIXPWhrrM5s143OD9cQVL_JOt-kKMRMtS2EK3B53IPLM_4mu8w1tG0WIPbexcRZlymXQW8H30PeQA-uATdknXIOwlP02Kg2wrPdPkffP328XH7Jz799_rr8cJ7rsqBDzrSpRYNZrUWBK61KVTHDDKe1YNAYtsKalSAEoRU3qqS0FLSmeMUFrBQBxubodKvbj6sOGp0qCKqVfbCdChvplZV_3jh7La_8jWSiJEVVJYHXO4Hgf44QB9nZOLWqHPgxSlKQNFCe4P9AMSclJwVP6MsDdO3H4NIkZCJ4VfNC1Il68Xvxv6re_1YCXu0AFbVqTVBO23jP1SwtMT1XbzkdfIwBjNR2UIP1U8-2lQTLyUByLScDyclAUwzfVUoPUvfqDya93yZB-tobC0FGbcFpaGwAPcjG24fTTw_SdWudTR3-gA3E-1HJSCWWF5OtJ1cThsndNkfv_i7wr9dvAXWQBnQ |
CODEN | JACIBY |
CitedBy_id | crossref_primary_10_1097_01_ASW_0000547414_38888_8d crossref_primary_10_1038_s41551_017_0143_4 crossref_primary_10_1016_j_jaci_2015_01_029 crossref_primary_10_1111_pai_13189 crossref_primary_10_1016_j_jaci_2022_06_024 crossref_primary_10_1111_all_12661 crossref_primary_10_4168_aair_2018_10_3_189 crossref_primary_10_1586_14760584_2015_1050385 crossref_primary_10_1016_j_clim_2015_05_023 crossref_primary_10_1111_all_13436 crossref_primary_10_1111_all_15931 crossref_primary_10_1586_1744666X_2016_1147349 crossref_primary_10_1111_1541_4337_12472 crossref_primary_10_1111_all_12989 crossref_primary_10_1111_cea_12324 crossref_primary_10_1016_j_jaci_2015_02_025 crossref_primary_10_1016_j_jaci_2022_05_025 crossref_primary_10_1586_1744666X_2016_1165093 crossref_primary_10_1111_cea_14024 crossref_primary_10_1111_all_13918 crossref_primary_10_1002_eji_202249983 crossref_primary_10_1186_s40413_015_0063_2 crossref_primary_10_1097_ACI_0000000000000480 crossref_primary_10_1080_10408398_2023_2181755 crossref_primary_10_1172_JCI164501 crossref_primary_10_1016_j_jaci_2014_12_1908 crossref_primary_10_1038_pr_2017_12 crossref_primary_10_1038_s41467_024_45058_9 crossref_primary_10_1111_all_15543 crossref_primary_10_1159_000375406 crossref_primary_10_1155_2017_5746031 crossref_primary_10_1586_14760584_2014_948861 crossref_primary_10_1111_all_15749 crossref_primary_10_1111_cea_12554 crossref_primary_10_1016_j_jaci_2017_10_010 crossref_primary_10_1038_s41541_017_0014_8 crossref_primary_10_1111_cea_12552 crossref_primary_10_1513_AnnalsATS_201507_431MG crossref_primary_10_1038_jid_2015_162 crossref_primary_10_1016_j_compbiolchem_2017_08_016 crossref_primary_10_1159_000525293 crossref_primary_10_1016_j_jaci_2015_08_046 crossref_primary_10_4168_aair_2023_15_2_125 crossref_primary_10_1007_s11882_015_0587_0 crossref_primary_10_2217_imt_2021_0133 crossref_primary_10_1016_j_jaci_2021_03_030 crossref_primary_10_1111_sji_12344 crossref_primary_10_3389_fimmu_2020_568598 crossref_primary_10_1111_all_13295 crossref_primary_10_1111_all_15276 crossref_primary_10_1016_j_iac_2015_09_001 crossref_primary_10_1016_j_jaci_2017_09_041 crossref_primary_10_1016_j_immuni_2020_07_025 crossref_primary_10_1016_j_jaci_2015_07_031 crossref_primary_10_3389_fimmu_2018_01408 crossref_primary_10_1038_nri_2016_111 crossref_primary_10_1111_all_12524 crossref_primary_10_1111_cea_12343 crossref_primary_10_2217_imt_16_1 crossref_primary_10_1016_j_ebiom_2018_09_016 crossref_primary_10_3389_fimmu_2022_916778 crossref_primary_10_1016_j_coph_2015_05_003 crossref_primary_10_1016_j_pharmthera_2022_108115 crossref_primary_10_2147_JAA_S288886 crossref_primary_10_1016_j_jaci_2022_01_016 crossref_primary_10_1007_s00005_017_0501_7 crossref_primary_10_1007_s11882_018_0801_y crossref_primary_10_1038_s41385_018_0038_z crossref_primary_10_1126_scitranslmed_aam9171 crossref_primary_10_1016_j_anai_2018_01_004 crossref_primary_10_1016_j_smim_2017_08_008 crossref_primary_10_1080_21645515_2017_1409315 crossref_primary_10_3389_fimmu_2015_00456 crossref_primary_10_1080_07391102_2019_1651673 crossref_primary_10_1111_all_15966 crossref_primary_10_1016_j_iac_2015_08_003 crossref_primary_10_1038_ncomms12614 crossref_primary_10_1016_j_iac_2015_08_004 crossref_primary_10_1111_all_13867 crossref_primary_10_1016_j_iac_2015_08_002 crossref_primary_10_1097_ACI_0000000000000216 crossref_primary_10_1111_cea_12653 crossref_primary_10_1016_j_coi_2020_02_005 crossref_primary_10_1016_j_mucimm_2024_03_012 crossref_primary_10_1111_pai_13042 crossref_primary_10_1007_s00105_014_3559_8 crossref_primary_10_1016_j_iac_2015_12_004 crossref_primary_10_2217_imt_14_47 crossref_primary_10_1016_j_jaci_2018_10_016 crossref_primary_10_1111_imm_12772 crossref_primary_10_1002_eji_201545869 crossref_primary_10_1016_j_jaci_2016_06_010 |
Cites_doi | 10.1016/j.jim.2008.09.014 10.1046/j.1365-2222.1998.00432.x 10.1038/ni.1826 10.1038/nri1934 10.1016/j.jaci.2010.03.037 10.1038/ni1490 10.4049/jimmunol.151.5.2426 10.1111/j.1365-2249.2010.04148.x 10.1111/j.1398-9995.2005.00699.x 10.1084/jem.187.1.129 10.1084/jem.20030916 10.1084/jem.187.6.875 10.1016/j.jaci.2012.07.056 10.1016/j.jaci.2006.05.003 10.1016/j.jaci.2011.08.034 10.1038/ni.2035 10.1159/000236567 10.1016/j.jaci.2005.12.1358 10.1084/jem.20110236 10.4168/aair.2011.3.1.11 10.1038/ni1467 10.1002/1521-4141(200010)30:10<2972::AID-IMMU2972>3.0.CO;2-# 10.1172/JCI8476 10.4049/jimmunol.1000405 10.1016/j.immuni.2008.08.001 10.4049/jimmunol.172.5.2763 10.4049/jimmunol.166.11.6665 10.1084/jem.20032058 10.1159/000331868 10.1146/annurev.iy.11.040193.003501 10.1084/jem.20091885 10.1056/NEJM199908123410702 10.4049/jimmunol.180.11.7193 10.4049/jimmunol.174.6.3352 10.1084/jem.186.9.1407 |
ContentType | Journal Article |
Copyright | 2013 American Academy of Allergy, Asthma & Immunology American Academy of Allergy, Asthma & Immunology 2015 INIST-CNRS Copyright © 2013 American Academy of Allergy, Asthma & Immunology. Published by Mosby, Inc. All rights reserved. Copyright Elsevier Limited Mar 2014 2013 American Academy of Allergy, Asthma and Immunology. Published by Mosby, Inc. All rights reserved. 2013 |
Copyright_xml | – notice: 2013 American Academy of Allergy, Asthma & Immunology – notice: American Academy of Allergy, Asthma & Immunology – notice: 2015 INIST-CNRS – notice: Copyright © 2013 American Academy of Allergy, Asthma & Immunology. Published by Mosby, Inc. All rights reserved. – notice: Copyright Elsevier Limited Mar 2014 – notice: 2013 American Academy of Allergy, Asthma and Immunology. Published by Mosby, Inc. All rights reserved. 2013 |
DBID | AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM 7SS 7T5 H94 K9. NAPCQ 7X8 5PM |
DOI | 10.1016/j.jaci.2013.10.054 |
DatabaseName | CrossRef Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Entomology Abstracts (Full archive) Immunology Abstracts AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Premium MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Entomology Abstracts AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Premium Immunology Abstracts MEDLINE - Academic |
DatabaseTitleList | MEDLINE AIDS and Cancer Research Abstracts MEDLINE - Academic Entomology Abstracts |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1097-6825 |
EndPage | 879.e7 |
ExternalDocumentID | PMC3961577 3556035951 24373351 28383894 10_1016_j_jaci_2013_10_054 S0091674913017491 1_s2_0_S0091674913017491 |
Genre | Journal Article Research Support, N.I.H., Extramural |
GrantInformation_xml | – fundername: National Institute of Allergy and Infectious Diseases (NIAID) – fundername: National Institutes of Health (NIH) – fundername: European Academy of Allergy and Clinical Immunology (EAACI)–World Allergy Organization (WAO) – fundername: NIH grantid: AI095074 – fundername: ALK-Abelló, Novartis, Stallergenes (Spain), and Letti (Spain) – fundername: NIAID NIH HHS grantid: AI095074 – fundername: NIAID NIH HHS grantid: HHSN272200700046C – fundername: NIAID NIH HHS grantid: R01 AI095074 – fundername: Medical Research Council grantid: G1000758 |
GroupedDBID | --- --K --M -~X .1- .55 .FO .GJ .XZ .~1 0R~ 1B1 1P~ 1RT 1~. 1~5 354 3O- 4.4 457 4G. 53G 5GY 5RE 5VS 7-5 71M 8F7 8FE 8FH 8P~ 9JM AAAJQ AABNK AAEDT AAEDW AAFWJ AAIKJ AAKOC AALRI AAOAW AAQFI AAQXK AARKO AATTM AAXKI AAXUO AAYWO ABBQC ABFNM ABJNI ABLJU ABMAC ABMZM ABOCM ABWVN ABXDB ACDAQ ACGFO ACGFS ACIEU ACPRK ACRLP ACRPL ACVFH ADBBV ADCNI ADEZE ADFRT ADMUD ADNMO ADVLN ADXHL AEBSH AEIPS AEKER AENEX AEUPX AFFNX AFJKZ AFPUW AFRAH AFRHN AFTJW AFXIZ AGCQF AGEKW AGHFR AGQPQ AGUBO AGYEJ AHHHB AHMBA AIEXJ AIGII AIIUN AIKHN AITUG AJRQY AJUYK AKBMS AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ ANKPU ANZVX APXCP ASPBG AVWKF AXJTR AZFZN BKOJK BLXMC BNPGV BPHCQ BVXVI C45 CAG CJTIS COF CS3 DU5 EBS EFJIC EFKBS EJD EO8 EO9 EP2 EP3 EX3 F5P FDB FEDTE FGOYB FIRID FNPLU FYGXN G-2 G-Q GBLVA HDU HMK HMO HVGLF HZ~ IHE J1W J5H K-O KOM L7B LK8 LUGTX M27 M41 MO0 N4W N9A O-L O9- O9~ OAUVE OBH ODZKP OHH OHT OK0 OK1 OVD OZT P-8 P-9 P2P PC. PQQKQ PROAC Q38 R2- ROL RPZ SAE SCC SDF SDG SDP SEL SES SEW SJN SPCBC SSH SSI SSZ T5K TEORI TWZ UGJ UNMZH UV1 WH7 WOW WUQ X7M XFW YOC YQI YQJ Z5R ZGI ZXP ZY1 ~02 ~G- ~KM AACTN RIG AAYXX AGRNS CITATION IQODW CGR CUY CVF ECM EIF NPM 7SS 7T5 H94 K9. NAPCQ 7X8 5PM |
ID | FETCH-LOGICAL-c652t-3cf89d038c9507ca6a73f3f42893edf3b0c36e991274fa622692820b49eba1e33 |
IEDL.DBID | .~1 |
ISSN | 0091-6749 1097-6825 |
IngestDate | Thu Aug 21 14:08:52 EDT 2025 Thu Jul 10 18:32:21 EDT 2025 Fri Jul 11 06:29:36 EDT 2025 Wed Aug 13 07:30:07 EDT 2025 Mon Jul 21 05:53:03 EDT 2025 Wed Apr 02 07:17:46 EDT 2025 Tue Jul 01 04:32:24 EDT 2025 Thu Apr 24 23:08:15 EDT 2025 Sun Apr 06 06:53:40 EDT 2025 Wed Apr 02 07:27:48 EDT 2025 Tue Aug 26 19:48:29 EDT 2025 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 3 |
Keywords | ASIT pollen pMHCII allergy peripheral tolerance T cells CD4 PE Immunotherapy peptide–MHC class II tetramer ex vivo epitope TGP Allergen-specific immunotherapy Timothy grass pollen Peptide–MHC class II Phycoerythrin Allergy Immunopathology CD4 T lymphocyte Immune response Antigenic determinant Peptides Major histocompatibility system Class II histocompatibility antigen Tolerance Immunology Treatment peptide-MHC class II tetramer Ex vivo Tetramer T-Lymphocyte Pollen Allergen |
Language | English |
License | https://www.elsevier.com/tdm/userlicense/1.0 CC BY 4.0 Copyright © 2013 American Academy of Allergy, Asthma & Immunology. Published by Mosby, Inc. All rights reserved. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c652t-3cf89d038c9507ca6a73f3f42893edf3b0c36e991274fa622692820b49eba1e33 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 ObjectType-Article-2 ObjectType-Feature-1 |
OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/3961577 |
PMID | 24373351 |
PQID | 1644784598 |
PQPubID | 105664 |
PageCount | 8 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_3961577 proquest_miscellaneous_1516744615 proquest_miscellaneous_1504164154 proquest_journals_1644784598 pubmed_primary_24373351 pascalfrancis_primary_28383894 crossref_citationtrail_10_1016_j_jaci_2013_10_054 crossref_primary_10_1016_j_jaci_2013_10_054 elsevier_sciencedirect_doi_10_1016_j_jaci_2013_10_054 elsevier_clinicalkeyesjournals_1_s2_0_S0091674913017491 elsevier_clinicalkey_doi_10_1016_j_jaci_2013_10_054 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2014-03-01 |
PublicationDateYYYYMMDD | 2014-03-01 |
PublicationDate_xml | – month: 03 year: 2014 text: 2014-03-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | New York, NY |
PublicationPlace_xml | – name: New York, NY – name: United States – name: St. Louis |
PublicationTitle | Journal of allergy and clinical immunology |
PublicationTitleAlternate | J Allergy Clin Immunol |
PublicationYear | 2014 |
Publisher | Elsevier Inc Elsevier Elsevier Limited |
Publisher_xml | – name: Elsevier Inc – name: Elsevier – name: Elsevier Limited |
References | Lissina, Ladell, Skowera, Clement, Edwards, Seggewiss (bib11) 2009; 340 Sallusto, Lenig, Mackay, Lanzavecchia (bib16) 1998; 187 Pepper, Linehan, Pagan, Zell, Dileepan, Cleary (bib19) 2010; 11 Margot, Ford, Evavold (bib30) 2005; 174 Oseroff, Peters, Pasquetto, Moutaftsi, Sidney, Panchanathan (bib28) 2008; 180 Steinman (bib29) 2008; 29 Wilson, Lima, Durham (bib2) 2005; 60 Fujita, Meyer, Akdis, Akdis (bib3) 2012; 96 Maggi (bib4) 2010; 161 Wherry (bib18) 2011; 12 Hintzen, de Jong, Lens, Brouwer, Baars, van Lier (bib32) 1993; 151 Zhao, Zhao, Fett, Trandem, Fleming, Perlman (bib25) 2011; 208 Bonecchi, Bianchi, Bordignon, D'Ambrosio, Lang, Borsatti (bib14) 1998; 187 Larche, Akdis, Valenta (bib6) 2006; 6 Kwok, Roti, Delong, Tan, Wambre, James (bib12) 2010; 125 Dahl, Kapp, Colombo, de Monchy, Rak, Emminger (bib8) 2006; 118 Vrtala, Grote, Duchene, Van, Kraft, Scheiner (bib7) 1993; 102 Durham, Walker, Varga, Jacobson, O'Brien, Noble (bib1) 1999; 341 Muller, Karamfilov, Kahlert, Stuwe, Fahlbusch, Cromwell (bib21) 1998; 28 Oseroff, Sidney, Kotturi, Kolla, Alam, Broide (bib22) 2010; 185 Skokos, Shakhar, Varma, Waite, Cameron, Lindquist (bib31) 2007; 8 Shafiani, Tucker-Heard, Kariyone, Takatsu, Urdahl (bib24) 2010; 207 Sercarz, Lehmann, Ametani, Benichou, Miller, Moudgil (bib27) 1993; 11 Reefer, Carneiro, Custis, Platts-Mills, Sung, Hammer (bib23) 2004; 172 Akkoc, Akdis, Akdis (bib5) 2011; 3 Hendriks, Xiao, Borst (bib20) 2003; 198 Mobs, Ipsen, Mayer, Slotosch, Petersen, Wurtzen (bib34) 2012; 130 Wambre, Delong, James, LaFond, Robinson, Kwok (bib17) 2012; 129 Hamann, Baars, Rep, Hooibrink, Kerkhof-Garde, Klein (bib33) 1997; 186 Acosta-Rodriguez, Rivino, Geginat, Jarrossay, Gattorno, Lanzavecchia (bib13) 2007; 8 Akdis, Verhagen, Taylor, Karamloo, Karagiannidis, Crameri (bib26) 2004; 199 Cosmi, Annunziato, Galli, Maggi, Nagata, Romagnani (bib15) 2000; 30 Novak, Liu, Nepom, Kwok (bib10) 1999; 104 Durham, Yang, Pedersen, Johansen, Rak (bib9) 2006; 117 Durham (10.1016/j.jaci.2013.10.054_bib1) 1999; 341 Pepper (10.1016/j.jaci.2013.10.054_bib19) 2010; 11 Wambre (10.1016/j.jaci.2013.10.054_bib17) 2012; 129 Lissina (10.1016/j.jaci.2013.10.054_bib11) 2009; 340 Shafiani (10.1016/j.jaci.2013.10.054_bib24) 2010; 207 Maggi (10.1016/j.jaci.2013.10.054_bib4) 2010; 161 Akdis (10.1016/j.jaci.2013.10.054_bib26) 2004; 199 Larche (10.1016/j.jaci.2013.10.054_bib6) 2006; 6 Wherry (10.1016/j.jaci.2013.10.054_bib18) 2011; 12 Novak (10.1016/j.jaci.2013.10.054_bibE1) 2001; 166 Vrtala (10.1016/j.jaci.2013.10.054_bib7) 1993; 102 Sallusto (10.1016/j.jaci.2013.10.054_bib16) 1998; 187 Mobs (10.1016/j.jaci.2013.10.054_bib34) 2012; 130 Zhao (10.1016/j.jaci.2013.10.054_bib25) 2011; 208 Dahl (10.1016/j.jaci.2013.10.054_bib8) 2006; 118 Fujita (10.1016/j.jaci.2013.10.054_bib3) 2012; 96 Hamann (10.1016/j.jaci.2013.10.054_bib33) 1997; 186 Oseroff (10.1016/j.jaci.2013.10.054_bib22) 2010; 185 Acosta-Rodriguez (10.1016/j.jaci.2013.10.054_bib13) 2007; 8 Steinman (10.1016/j.jaci.2013.10.054_bib29) 2008; 29 Novak (10.1016/j.jaci.2013.10.054_bib10) 1999; 104 Oseroff (10.1016/j.jaci.2013.10.054_bib28) 2008; 180 Akkoc (10.1016/j.jaci.2013.10.054_bib5) 2011; 3 Hintzen (10.1016/j.jaci.2013.10.054_bib32) 1993; 151 Skokos (10.1016/j.jaci.2013.10.054_bib31) 2007; 8 Margot (10.1016/j.jaci.2013.10.054_bib30) 2005; 174 Wilson (10.1016/j.jaci.2013.10.054_bib2) 2005; 60 Durham (10.1016/j.jaci.2013.10.054_bib9) 2006; 117 Cosmi (10.1016/j.jaci.2013.10.054_bib15) 2000; 30 Muller (10.1016/j.jaci.2013.10.054_bib21) 1998; 28 Sercarz (10.1016/j.jaci.2013.10.054_bib27) 1993; 11 Bonecchi (10.1016/j.jaci.2013.10.054_bib14) 1998; 187 Reefer (10.1016/j.jaci.2013.10.054_bib23) 2004; 172 Hendriks (10.1016/j.jaci.2013.10.054_bib20) 2003; 198 Kwok (10.1016/j.jaci.2013.10.054_bib12) 2010; 125 |
References_xml | – volume: 6 start-page: 761 year: 2006 end-page: 771 ident: bib6 article-title: Immunological mechanisms of allergen-specific immunotherapy publication-title: Nat Rev Immunol – volume: 118 start-page: 434 year: 2006 end-page: 440 ident: bib8 article-title: Efficacy and safety of sublingual immunotherapy with grass allergen tablets for seasonal allergic rhinoconjunctivitis publication-title: J Allergy Clin Immunol – volume: 96 start-page: 30 year: 2012 end-page: 38 ident: bib3 article-title: Mechanisms of immune tolerance to allergens publication-title: Chem Immunol Allergy – volume: 8 start-page: 639 year: 2007 end-page: 646 ident: bib13 article-title: Surface phenotype and antigenic specificity of human interleukin 17-producing T helper memory cells publication-title: Nat Immunol – volume: 3 start-page: 11 year: 2011 end-page: 20 ident: bib5 article-title: Update in the mechanisms of allergen-specific immunotherapy publication-title: Allergy Asthma Immunol Res – volume: 8 start-page: 835 year: 2007 end-page: 844 ident: bib31 article-title: Peptide-MHC potency governs dynamic interactions between T cells and dendritic cells in lymph nodes publication-title: Nat Immunol – volume: 117 start-page: 802 year: 2006 end-page: 809 ident: bib9 article-title: Sublingual immunotherapy with once-daily grass allergen tablets: a randomized controlled trial in seasonal allergic rhinoconjunctivitis publication-title: J Allergy Clin Immunol – volume: 12 start-page: 492 year: 2011 end-page: 499 ident: bib18 article-title: T cell exhaustion publication-title: Nat Immunol – volume: 208 start-page: 1571 year: 2011 end-page: 1577 ident: bib25 article-title: IFN-gamma- and IL-10-expressing virus epitope-specific Foxp3(+) T reg cells in the central nervous system during encephalomyelitis publication-title: J Exp Med – volume: 129 start-page: 544 year: 2012 end-page: 551 ident: bib17 article-title: Differentiation stage determines pathologic and protective allergen-specific CD4+ T-cell outcomes during specific immunotherapy publication-title: J Allergy Clin Immunol – volume: 207 start-page: 1409 year: 2010 end-page: 1420 ident: bib24 article-title: Pathogen-specific regulatory T cells delay the arrival of effector T cells in the lung during early tuberculosis publication-title: J Exp Med – volume: 185 start-page: 943 year: 2010 end-page: 955 ident: bib22 article-title: Molecular determinants of T cell epitope recognition to the common Timothy grass allergen publication-title: J Immunol – volume: 180 start-page: 7193 year: 2008 end-page: 7202 ident: bib28 article-title: Dissociation between epitope hierarchy and immunoprevalence in CD8 responses to vaccinia virus western reserve publication-title: J Immunol – volume: 187 start-page: 129 year: 1998 end-page: 134 ident: bib14 article-title: Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s publication-title: J Exp Med – volume: 187 start-page: 875 year: 1998 end-page: 883 ident: bib16 article-title: Flexible programs of chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes publication-title: J Exp Med – volume: 130 start-page: 1108 year: 2012 end-page: 1116.e6 ident: bib34 article-title: Birch pollen immunotherapy results in long-term loss of Bet v 1-specific T(H)2 responses, transient T(R)1 activation, and synthesis of IgE-blocking antibodies publication-title: J Allergy Clin Immunol – volume: 60 start-page: 4 year: 2005 end-page: 12 ident: bib2 article-title: Sublingual immunotherapy for allergic rhinitis: systematic review and meta-analysis publication-title: Allergy – volume: 340 start-page: 11 year: 2009 end-page: 24 ident: bib11 article-title: Protein kinase inhibitors substantially improve the physical detection of T-cells with peptide-MHC tetramers publication-title: J Immunol Methods – volume: 172 start-page: 2763 year: 2004 end-page: 2772 ident: bib23 article-title: A role for IL-10-mediated HLA-DR7-restricted T cell-dependent events in development of the modified Th2 response to cat allergen publication-title: J Immunol – volume: 125 start-page: 1407 year: 2010 end-page: 1409 ident: bib12 article-title: Direct ex vivo analysis of allergen-specific CD4+ T cells publication-title: J Allergy Clin Immunol – volume: 198 start-page: 1369 year: 2003 end-page: 1380 ident: bib20 article-title: CD27 promotes survival of activated T cells and complements CD28 in generation and establishment of the effector T cell pool publication-title: J Exp Med – volume: 102 start-page: 160 year: 1993 end-page: 169 ident: bib7 article-title: Properties of tree and grass pollen allergens: reinvestigation of the linkage between solubility and allergenicity publication-title: Int Arch Allergy Immunol – volume: 11 start-page: 83 year: 2010 end-page: 89 ident: bib19 article-title: Different routes of bacterial infection induce long-lived TH1 memory cells and short-lived TH17 cells publication-title: Nat Immunol – volume: 11 start-page: 729 year: 1993 end-page: 766 ident: bib27 article-title: Dominance and crypticity of T cell antigenic determinants publication-title: Annu Rev Immunol – volume: 199 start-page: 1567 year: 2004 end-page: 1575 ident: bib26 article-title: Immune responses in healthy and allergic individuals are characterized by a fine balance between allergen-specific T regulatory 1 and T helper 2 cells publication-title: J Exp Med – volume: 341 start-page: 468 year: 1999 end-page: 475 ident: bib1 article-title: Long-term clinical efficacy of grass-pollen immunotherapy publication-title: N Engl J Med – volume: 161 start-page: 10 year: 2010 end-page: 18 ident: bib4 article-title: T-cell responses induced by allergen-specific immunotherapy publication-title: Clin Exp Immunol – volume: 29 start-page: 319 year: 2008 end-page: 324 ident: bib29 article-title: Dendritic cells in vivo: a key target for a new vaccine science publication-title: Immunity – volume: 186 start-page: 1407 year: 1997 end-page: 1418 ident: bib33 article-title: Phenotypic and functional separation of memory and effector human CD8+ T cells publication-title: J Exp Med – volume: 104 start-page: R63 year: 1999 end-page: R67 ident: bib10 article-title: MHC class II tetramers identify peptide-specific human CD4(+) T cells proliferating in response to influenza A antigen publication-title: J Clin Invest – volume: 151 start-page: 2426 year: 1993 end-page: 2435 ident: bib32 article-title: Regulation of CD27 expression on subsets of mature T-lymphocytes publication-title: J Immunol – volume: 28 start-page: 1538 year: 1998 end-page: 1548 ident: bib21 article-title: Mapping of T-cell epitopes of Phl p 5: evidence for crossreacting and non-crossreacting T-cell epitopes within Phl p 5 isoallergens publication-title: Clin Exp Allergy – volume: 30 start-page: 2972 year: 2000 end-page: 2979 ident: bib15 article-title: CRTH2 is the most reliable marker for the detection of circulating human type 2 Th and type 2 T cytotoxic cells in health and disease publication-title: Eur J Immunol – volume: 174 start-page: 3352 year: 2005 end-page: 3358 ident: bib30 article-title: Amelioration of established experimental autoimmune encephalomyelitis by an MHC anchor-substituted variant of proteolipid protein 139-151 publication-title: J Immunol – volume: 340 start-page: 11 year: 2009 ident: 10.1016/j.jaci.2013.10.054_bib11 article-title: Protein kinase inhibitors substantially improve the physical detection of T-cells with peptide-MHC tetramers publication-title: J Immunol Methods doi: 10.1016/j.jim.2008.09.014 – volume: 28 start-page: 1538 year: 1998 ident: 10.1016/j.jaci.2013.10.054_bib21 article-title: Mapping of T-cell epitopes of Phl p 5: evidence for crossreacting and non-crossreacting T-cell epitopes within Phl p 5 isoallergens publication-title: Clin Exp Allergy doi: 10.1046/j.1365-2222.1998.00432.x – volume: 11 start-page: 83 year: 2010 ident: 10.1016/j.jaci.2013.10.054_bib19 article-title: Different routes of bacterial infection induce long-lived TH1 memory cells and short-lived TH17 cells publication-title: Nat Immunol doi: 10.1038/ni.1826 – volume: 6 start-page: 761 year: 2006 ident: 10.1016/j.jaci.2013.10.054_bib6 article-title: Immunological mechanisms of allergen-specific immunotherapy publication-title: Nat Rev Immunol doi: 10.1038/nri1934 – volume: 125 start-page: 1407 year: 2010 ident: 10.1016/j.jaci.2013.10.054_bib12 article-title: Direct ex vivo analysis of allergen-specific CD4+ T cells publication-title: J Allergy Clin Immunol doi: 10.1016/j.jaci.2010.03.037 – volume: 8 start-page: 835 year: 2007 ident: 10.1016/j.jaci.2013.10.054_bib31 article-title: Peptide-MHC potency governs dynamic interactions between T cells and dendritic cells in lymph nodes publication-title: Nat Immunol doi: 10.1038/ni1490 – volume: 151 start-page: 2426 year: 1993 ident: 10.1016/j.jaci.2013.10.054_bib32 article-title: Regulation of CD27 expression on subsets of mature T-lymphocytes publication-title: J Immunol doi: 10.4049/jimmunol.151.5.2426 – volume: 161 start-page: 10 year: 2010 ident: 10.1016/j.jaci.2013.10.054_bib4 article-title: T-cell responses induced by allergen-specific immunotherapy publication-title: Clin Exp Immunol doi: 10.1111/j.1365-2249.2010.04148.x – volume: 60 start-page: 4 year: 2005 ident: 10.1016/j.jaci.2013.10.054_bib2 article-title: Sublingual immunotherapy for allergic rhinitis: systematic review and meta-analysis publication-title: Allergy doi: 10.1111/j.1398-9995.2005.00699.x – volume: 187 start-page: 129 year: 1998 ident: 10.1016/j.jaci.2013.10.054_bib14 article-title: Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s publication-title: J Exp Med doi: 10.1084/jem.187.1.129 – volume: 198 start-page: 1369 year: 2003 ident: 10.1016/j.jaci.2013.10.054_bib20 article-title: CD27 promotes survival of activated T cells and complements CD28 in generation and establishment of the effector T cell pool publication-title: J Exp Med doi: 10.1084/jem.20030916 – volume: 187 start-page: 875 year: 1998 ident: 10.1016/j.jaci.2013.10.054_bib16 article-title: Flexible programs of chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes publication-title: J Exp Med doi: 10.1084/jem.187.6.875 – volume: 130 start-page: 1108 year: 2012 ident: 10.1016/j.jaci.2013.10.054_bib34 article-title: Birch pollen immunotherapy results in long-term loss of Bet v 1-specific T(H)2 responses, transient T(R)1 activation, and synthesis of IgE-blocking antibodies publication-title: J Allergy Clin Immunol doi: 10.1016/j.jaci.2012.07.056 – volume: 118 start-page: 434 year: 2006 ident: 10.1016/j.jaci.2013.10.054_bib8 article-title: Efficacy and safety of sublingual immunotherapy with grass allergen tablets for seasonal allergic rhinoconjunctivitis publication-title: J Allergy Clin Immunol doi: 10.1016/j.jaci.2006.05.003 – volume: 129 start-page: 544 year: 2012 ident: 10.1016/j.jaci.2013.10.054_bib17 article-title: Differentiation stage determines pathologic and protective allergen-specific CD4+ T-cell outcomes during specific immunotherapy publication-title: J Allergy Clin Immunol doi: 10.1016/j.jaci.2011.08.034 – volume: 12 start-page: 492 year: 2011 ident: 10.1016/j.jaci.2013.10.054_bib18 article-title: T cell exhaustion publication-title: Nat Immunol doi: 10.1038/ni.2035 – volume: 102 start-page: 160 year: 1993 ident: 10.1016/j.jaci.2013.10.054_bib7 article-title: Properties of tree and grass pollen allergens: reinvestigation of the linkage between solubility and allergenicity publication-title: Int Arch Allergy Immunol doi: 10.1159/000236567 – volume: 117 start-page: 802 year: 2006 ident: 10.1016/j.jaci.2013.10.054_bib9 article-title: Sublingual immunotherapy with once-daily grass allergen tablets: a randomized controlled trial in seasonal allergic rhinoconjunctivitis publication-title: J Allergy Clin Immunol doi: 10.1016/j.jaci.2005.12.1358 – volume: 208 start-page: 1571 year: 2011 ident: 10.1016/j.jaci.2013.10.054_bib25 article-title: IFN-gamma- and IL-10-expressing virus epitope-specific Foxp3(+) T reg cells in the central nervous system during encephalomyelitis publication-title: J Exp Med doi: 10.1084/jem.20110236 – volume: 3 start-page: 11 year: 2011 ident: 10.1016/j.jaci.2013.10.054_bib5 article-title: Update in the mechanisms of allergen-specific immunotherapy publication-title: Allergy Asthma Immunol Res doi: 10.4168/aair.2011.3.1.11 – volume: 8 start-page: 639 year: 2007 ident: 10.1016/j.jaci.2013.10.054_bib13 article-title: Surface phenotype and antigenic specificity of human interleukin 17-producing T helper memory cells publication-title: Nat Immunol doi: 10.1038/ni1467 – volume: 30 start-page: 2972 year: 2000 ident: 10.1016/j.jaci.2013.10.054_bib15 article-title: CRTH2 is the most reliable marker for the detection of circulating human type 2 Th and type 2 T cytotoxic cells in health and disease publication-title: Eur J Immunol doi: 10.1002/1521-4141(200010)30:10<2972::AID-IMMU2972>3.0.CO;2-# – volume: 104 start-page: R63 year: 1999 ident: 10.1016/j.jaci.2013.10.054_bib10 article-title: MHC class II tetramers identify peptide-specific human CD4(+) T cells proliferating in response to influenza A antigen publication-title: J Clin Invest doi: 10.1172/JCI8476 – volume: 185 start-page: 943 year: 2010 ident: 10.1016/j.jaci.2013.10.054_bib22 article-title: Molecular determinants of T cell epitope recognition to the common Timothy grass allergen publication-title: J Immunol doi: 10.4049/jimmunol.1000405 – volume: 29 start-page: 319 year: 2008 ident: 10.1016/j.jaci.2013.10.054_bib29 article-title: Dendritic cells in vivo: a key target for a new vaccine science publication-title: Immunity doi: 10.1016/j.immuni.2008.08.001 – volume: 172 start-page: 2763 year: 2004 ident: 10.1016/j.jaci.2013.10.054_bib23 article-title: A role for IL-10-mediated HLA-DR7-restricted T cell-dependent events in development of the modified Th2 response to cat allergen publication-title: J Immunol doi: 10.4049/jimmunol.172.5.2763 – volume: 166 start-page: 6665 year: 2001 ident: 10.1016/j.jaci.2013.10.054_bibE1 article-title: Tetramer-guided epitope mapping: rapid identification and characterization of immunodominant CD4+ T cell epitopes from complex antigens publication-title: J Immunol doi: 10.4049/jimmunol.166.11.6665 – volume: 199 start-page: 1567 year: 2004 ident: 10.1016/j.jaci.2013.10.054_bib26 article-title: Immune responses in healthy and allergic individuals are characterized by a fine balance between allergen-specific T regulatory 1 and T helper 2 cells publication-title: J Exp Med doi: 10.1084/jem.20032058 – volume: 96 start-page: 30 year: 2012 ident: 10.1016/j.jaci.2013.10.054_bib3 article-title: Mechanisms of immune tolerance to allergens publication-title: Chem Immunol Allergy doi: 10.1159/000331868 – volume: 11 start-page: 729 year: 1993 ident: 10.1016/j.jaci.2013.10.054_bib27 article-title: Dominance and crypticity of T cell antigenic determinants publication-title: Annu Rev Immunol doi: 10.1146/annurev.iy.11.040193.003501 – volume: 207 start-page: 1409 year: 2010 ident: 10.1016/j.jaci.2013.10.054_bib24 article-title: Pathogen-specific regulatory T cells delay the arrival of effector T cells in the lung during early tuberculosis publication-title: J Exp Med doi: 10.1084/jem.20091885 – volume: 341 start-page: 468 year: 1999 ident: 10.1016/j.jaci.2013.10.054_bib1 article-title: Long-term clinical efficacy of grass-pollen immunotherapy publication-title: N Engl J Med doi: 10.1056/NEJM199908123410702 – volume: 180 start-page: 7193 year: 2008 ident: 10.1016/j.jaci.2013.10.054_bib28 article-title: Dissociation between epitope hierarchy and immunoprevalence in CD8 responses to vaccinia virus western reserve publication-title: J Immunol doi: 10.4049/jimmunol.180.11.7193 – volume: 174 start-page: 3352 year: 2005 ident: 10.1016/j.jaci.2013.10.054_bib30 article-title: Amelioration of established experimental autoimmune encephalomyelitis by an MHC anchor-substituted variant of proteolipid protein 139-151 publication-title: J Immunol doi: 10.4049/jimmunol.174.6.3352 – volume: 186 start-page: 1407 year: 1997 ident: 10.1016/j.jaci.2013.10.054_bib33 article-title: Phenotypic and functional separation of memory and effector human CD8+ T cells publication-title: J Exp Med doi: 10.1084/jem.186.9.1407 |
SSID | ssj0009389 |
Score | 2.453651 |
Snippet | Understanding the mechanisms by which the immune system induces and controls allergic inflammation at the T-cell epitope level is critical for the design of... Background Understanding the mechanisms by which the immune system induces and controls allergic inflammation at the T-cell epitope level is critical for the... Background: Understanding the mechanisms by which the immune system induces and controls allergic inflammation at the T-cell epitope level is critical for the... |
SourceID | pubmedcentral proquest pubmed pascalfrancis crossref elsevier |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 872 |
SubjectTerms | Allergens - immunology Allergies allergy Allergy and Immunology Biological and medical sciences CD4 CD4-Positive T-Lymphocytes - immunology Cytokines Desensitization, Immunologic epitope Epitopes, T-Lymphocyte - immunology ex vivo Fundamental and applied biological sciences. Psychology Fundamental immunology Grasses Humans Immune Tolerance Immunopathology Immunophenotyping Immunotherapy Lymphocytes Medical sciences Peptides peptide–MHC class II tetramer peripheral tolerance Phleum - immunology pollen Sarcoidosis. Granulomatous diseases of unproved etiology. Connective tissue diseases. Elastic tissue diseases. Vasculitis Statistical analysis T cell receptors T cells Th1 Cells - immunology Th2 Cells - immunology Tumor Necrosis Factor Receptor Superfamily, Member 7 - analysis |
Title | Specific immunotherapy modifies allergen-specific CD4+ T-cell responses in an epitope-dependent manner |
URI | https://www.clinicalkey.com/#!/content/1-s2.0-S0091674913017491 https://www.clinicalkey.es/playcontent/1-s2.0-S0091674913017491 https://dx.doi.org/10.1016/j.jaci.2013.10.054 https://www.ncbi.nlm.nih.gov/pubmed/24373351 https://www.proquest.com/docview/1644784598 https://www.proquest.com/docview/1504164154 https://www.proquest.com/docview/1516744615 https://pubmed.ncbi.nlm.nih.gov/PMC3961577 |
Volume | 133 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3fa9swEBalgzEYZb_ntgsa7K2otS3Zsh5LtpJttE8t9E3IssRcVsfU6UNf-rf3LpadZesyGHkIkU-JpTudPjnf3RHyKTWKY-Q3Mz6tmJBwQFGSG5ZKQB-lq0zi8NHA6Vk-uxDfLrPLLTIdYmGQVhl8f-_Tl946tByF2Txq6xpjfBVS6BV44QTfMIJdSLTyw_sVzUPxoofAKmEoHQJneo7XlbE10rv4ITK8MvG3zel5azqYMt_XungMjP7Oqfxlkzp5QXYCuqTH_QBeki3XvCJPT8P_56-JX5ab97WlNcaFhOirO3o9r6DVdRQrq2A4JusGwelncUDPGT7gpzc9oRbk6oaahroW_EHr2FBJd0GvDZbyekMuTr6cT2csVFpgNs_SBePWF6qKeWEV4ENrciO55x6OJoq7yvMytjx3ACXhDOtNDpBNwVEtLoVyJWqTvyXbzbxx7wm1Pi0q57gpVC4KI8o8Kw2W80hV7Lg1EUmGKdY2pCHHahg_9cA3u9KoFo1qwTZQS0QOxj5tn4RjozQfNKeH8FJwiBr2iI295GO9XBfWdKcT3aU61n_YXUSyseea6f7zFydrZjUODRAfvBQI7A92pld3AQBWFiJTRUQ-jpfBJ6AdmMbNb0Emg-WXwwoUm2RwEAIAbUTe9aa7ugHMd8UzGJlcM-pRAHOSr19p6h_L3ORcwTdKufufc7JHnsEn0ZP89sn24ubWfQDUtygny2U9IU-Ov36fnT0AHKVWTQ |
linkProvider | Elsevier |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwELdGJ8EkhPheYAwj8TaZJbHz4cepMHVs7VMn7c1yHFtkYmm0dA_899w1TkphFAn1IZJ918S-8_nn5D4I-RhryTHym2kXl0xkcECRGdcszgB9FLbUkcVXA9NZOrkUX6-Sqx0y7mNh0K3S2_7Opq-stW859rN53FQVxvhKdKGXYIUjvDwgu5idKhmR3ZOz88lsnXuX5x0KlhFDBh8707l5XWtToYcX_4ROXon42_70uNEtzJrryl3ch0d_d6v8ZZ86fUqeeIBJT7oxPCM7tn5OHk79J_QXxK0qzrvK0ApDQ3wA1g96syih1bYUi6tgRCZre8LxZ3FE5wzf8dPbzqcW6Kqa6praBkxCY1lfTHdJbzRW83pJLk-_zMcT5ostMJMm8ZJx43JZhjw3EiCi0anOuOMOTieS29LxIjQ8tYAm4RjrdAqoTcJpLSyEtAUKlL8io3pR231CjYvz0lquc5mKXIsiTQqNFT1iGVpudECifoqV8ZnIsSDGd9W7nF0rFItCsWAbiCUgRwNP0-Xh2ErNe8mpPsIUbKKCbWIrV3Yfl239sm5VpNpYheoP1QtIMnBuaO8_73i4oVbD0AD0wU8CwUGvZ2r9FIBhs1wkMg_Ih6EbzALqga7t4g5oEliBKSxCsY0GByEA0wbkdae66wfAlFc8gZFlG0o9EGBa8s2euvq2Sk_OJfxjlr35zzl5Tx5N5tMLdXE2O39L9qBHdD5_B2S0vL2z7wAELotDv8h_AqobWP4 |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Specific+immunotherapy+modifies+allergen-specific+CD4%2B+T-cell+responses+in+an+epitope-dependent+manner&rft.jtitle=Journal+of+allergy+and+clinical+immunology&rft.au=Wambre%2C+Erik&rft.au=DeLong%2C+Jonathan+H.&rft.au=James%2C+Eddie+A.&rft.au=Torres-Chinn%2C+Nadia&rft.date=2014-03-01&rft.pub=Elsevier+Inc&rft.issn=0091-6749&rft.volume=133&rft.issue=3&rft.spage=872&rft.epage=879.e7&rft_id=info:doi/10.1016%2Fj.jaci.2013.10.054&rft.externalDocID=S0091674913017491 |
thumbnail_m | http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F00916749%2FS0091674913X0017X%2Fcov150h.gif |